| CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric Patients Breakthrough Device Designation supported by original research recently published in the Journal of NeuroInterventional Surgery BOSTON, April 23, 2025 /PRNewswire/ – CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, today announced it has […] The post CereVasc, Inc. Receives FDA Breakthrough Device Designation for the eShunt® System for Use in Pediatric Patients appeared first on CereVasc |
Neurological Disease Device |
